Arquivos do dia: Abril 27, 2022
Sintomas persistentes de COVID-19 em estudo comunitário de 606.434 pessoas na Inglaterra.
27 Abr, 2022 | 16:41h
Comentário no Twitter
Thirty-eight percent of participants from a community-based study of symptoms following COVID-19 reported persistent symptoms that lasted 12 weeks or more, according to an article published in @NatureComms. https://t.co/sAEutdOkSS pic.twitter.com/oCyyXGIRbk
— Nature Portfolio (@NaturePortfolio) April 20, 2022
Covid-19: estudo mostra que somente 1/4 dos pacientes admitidos em hospital sentem-se completamente recuperados após 1 ano.
27 Abr, 2022 | 16:39hComentário convidado: Long COVID: systemic inflammation and obesity as therapeutic targets – The Lancet Respiratory Medicine
Comentário no Twitter (fio – clique para saber mais)
PHOSP-COVID study:
– 232 (29%) of 804 pts fully recovered at 1y
– Female sex, obesity, & IMV = less likely to feel fully recovered
– inflamm mediators📈in those w/ most severe physical, mental health, & cognitive impairmentsRead it here: https://t.co/rVZuVDo4xl
— The Lancet Respiratory Medicine (@LancetRespirMed) April 25, 2022
Revisão | Tomada de decisões sobre imagens radiológicas na gestação.
27 Abr, 2022 | 16:36hMaking decisions about radiological imaging in pregnancy – The BMJ
Estudo de coorte | Gravidade da COVID-19 e trajetória da morbidade da saúde mental em populações de pacientes de 6 nações.
27 Abr, 2022 | 16:35hComunicado de imprensa: Study suggests association between severe COVID-19 and long-term mental health outcomes 16 months after an illness – Lancet
Comentário: Lasting depression and anxiety can follow severe case of Covid – NBC News
Comentário no Twitter (fio – clique para saber mais)
In our study published in the @TheLancetPH, we found that a mild course of acute illness (never bedridden due to #COVID19) was associated with a persistently lower risk of adverse #mentalhealth outcomes. https://t.co/aHBQTaOi4K
Several factors might contribute to this pattern🔽
— COVIDMENT research project (@COVIDMENT) April 11, 2022
Sim, recaídas após Paxlovid acontecem – e agora?
27 Abr, 2022 | 16:33hYes, Relapses After Paxlovid Happen — Now What? – HIV and ID Observations
Comentário no Twitter
Some additional thoughts about relapsing Covid19 after treatment with Paxlovid.
Bottom line — *lots* of unknowns, starting w/ how often it happens.
Looking forward to @pfizer sharing further data on the relapsing cases from their EPIC-HR study. https://t.co/1MMhqn4elw
— Paul Sax (@PaulSaxMD) April 25, 2022
M-A | Avaliação do benefício adicional do escore de cálcio das artérias coronárias além da avaliação de risco cardiovascular tradicional.
27 Abr, 2022 | 16:31hEvaluation of the Incremental Value of a Coronary Artery Calcium Score Beyond Traditional Cardiovascular Risk Assessment: A Systematic Review and Meta-analysis – JAMA Internal Medicine (gratuito por tempo limitado)
Comentário convidado: Addition of Coronary Artery Calcium Scores to Primary Prevention Risk Estimation Models—Primum Non Nocere – JAMA Internal Medicine (gratuito por tempo limitado)
Entrevista com a autora: Incremental Value of a Coronary Artery Calcium Score
Comentário no Twitter
Coronary artery calcium scans provide a small gain in CVD risk assessment and may have a role in selected patients. Potential harms include false positives, incidental findings, radiation, and cost. No evidence suggests that this provides clinical benefit. https://t.co/7bASFf26NF
— JAMA Internal Medicine (@JAMAInternalMed) April 25, 2022
Estudo randomizado por cluster | Dispositivo supraglótico para via aérea vs. entubação traqueal no tratamento inicial de parada cardíaca fora do hospital.
27 Abr, 2022 | 16:29hEstudo randomizado | Embolização de artéria uterina vs. miomectomia para mulheres na pré-menopausa com fibrose uterina que desejam evitar a histerectomia.
27 Abr, 2022 | 16:27hEstudo de coorte | Efetividade de doses de reforço homólogas vs. heterólogas para vacina com SARS-CoV-2 inativado.
27 Abr, 2022 | 16:26hComentários:
COVID-19 vaccine booster strategy: striving for best practice – The Lancet Global Health
Covid-19: Mix and match booster vaccination approach offers best protection, study reports – The BMJ
Comentário no Twitter
Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study https://t.co/0k7WlphoDV Heterologous booster provided ⬆️ protection than homologous one, especially when Coronavac vaccine had been used.
— Carlos del Rio (@CarlosdelRio7) April 25, 2022